| Literature DB >> 25035795 |
Jonathan Branney1, Alan C Breen2.
Abstract
BACKGROUND: Spinal manipulation for nonspecific neck pain is thought to work in part by improving inter-vertebral range of motion (IV-RoM), but it is difficult to measure this or determine whether it is related to clinical outcomes.Entities:
Keywords: Fluoroscopy; Manipulation; Neck pain; Patient-reported outcomes; Spine kinematics
Year: 2014 PMID: 25035795 PMCID: PMC4102240 DOI: 10.1186/s12998-014-0024-9
Source DB: PubMed Journal: Chiropr Man Therap ISSN: 2045-709X
Inclusion and exclusion criteria
| All participants | Inclusion criteria: Male and female, Age 18 – 70 years,
Able and willing to participate, No large radiological
investigations or treatments in the past two years (effective
dose > 10 mSv), Capable of giving informed
consent, Not pregnant or likely to be pregnant, Willing for general
practitioner to be informed about participation. |
| Exclusion criteria: History of cervical spine surgery, Poor
understanding of English, Current involvement as a subject in
another research study. | |
| Patients | Inclusion criteria: Mechanical neck pain (reproducible by neck
movement/provocation tests) and no identifiable aetiology e.g.
infection, inflammatory disease, Pain located within the area
defined by the Neck Pain Task Force, Self-reported pain rating 3 or
more on a 11-point numerical rating scale, Pain of at least
2 weeks duration, No contraindications to spinal manipulative
therapy. |
| Exclusion criteria: Non-mechanical neck pain, Depression history,
Litigation/compensation pending, Manual therapy already received
for this episode of neck pain, Primary complaint of arm pain,
Traumatic onset of this neck pain episode, Central hypersensitivity
as assessed by pressure algometry. | |
| Healthy volunteers | Inclusion criteria: No activity-limiting neck pain lasting more
than 24 hours in the last 12 months, No current neck
pain, dizziness or vertigo (unsteadiness). |
| Exclusion criteria: Cervical/thoracic spine manipulation in week prior to baseline imaging. |
Figure 1Study flow diagram.
Figure 2Fluoroscope and motion frame configuration.
Figure 3Examples of IV-RoM compared to global motion. IV-RoMs at individual levels are shown as peaks of coloured lines and the end of global motion as a dotted line.
Accuracy, repeatability and thresholds for hypomobility (HT) and minimal detectable change (MDC) in IV-RoM in healthy volunteers
| | ||||
|---|---|---|---|---|
| Agreement (SEM) | | | | |
| C1-2 | 0.8 | 0.8 | 1.1 | 0.4 |
| C2-3 | 0.3 | 0.4 | 0.8 | 0.7 |
| C3-4 | 0.5 | 0.3 | 1.0 | 1.0 |
| C4-5 | 0.6 | 0.5 | 0.8 | 0.8 |
| C5-6 | 0.5 | 0.3 | 1.1 | 1.0 |
| Reliability (ICC, 95% CI) | * | μ | * | μ |
| C1-2 | 0.97 (0.89-0.99) | 0.96 (0.82-0.99) | 0.90 (0.64-0.97) | 0.97 (0.88-0.99) |
| C2-3 | 0.97 (0.90-0.99) | 0.97 (0.90-0.99) | 0.95 (0.80-0.99) | 0.95 (0.71-0.98) |
| C3-4 | 0.99 (0.98-0.99) | 0.99 (0.98-0.99) | 0.92 (0.71-0.98) | 0.97 (0.87-0.99) |
| C4-5 | 0.97 (0.89-0.99) | 0.97 (0.89-0.99) | 0.97 (0.89-0.99) | 0.97 (0.85-0.99) |
| C5-6 | 0.99 (0.97-0.99) | 0.99 (0.97-0.99) | 0.97 (0.85-0.99) | 0.97 (0.85-0.98) |
| Thresholds (o) | HT | MDC | HT | MDC |
| C1-2 | 1.3 | 3.8 | 1.1 | 4.4 |
| C2-3 | 0.8 | 3.0 | 0.9 | 4.5 |
| C3-4 | 1.8 | 3.9 | 2.3 | 6.4 |
| C4-5 | 2.3 | 3.4 | 3.5 | 4.7 |
| C5-6 | 1.1 | 3.4 | 1.3 | 5.0 |
* = ICC(3C,1), μ = ICC (2C,1), two-way single measure mixed effects model (consistency).
Baseline characteristics of participants
| N | 29 | 30 | |
| Age (years) | 39.7 (13.1) | 40.9 (13.1) | 0.72† |
| Females | 21/29 | 21/30 | 0.23‡ |
| With skeletal variants/anomalies | 9/29 | 5/29 | 0.23‡ |
| Regional range of motion in flexion (degrees-SD) | 49 (6.7) | 53 (7.2) | 0.04† |
| Regional range of motion in extension (degrees-SD) | 51 (7.2) | 56 (6.6) | 0.03† |
| Median pain duration, weeks (interquartile range) | 12 (2–36) | | |
| With other pain sites | 18/29 | - | - |
| Mean pain pressure threshold, kPa (SD) | 475 (160) | - | -- |
| Mean pain score/10 (SD) | 5 (1.5) | - | - |
| Mean NDI score/50 (SD) | 13 (6.7) | - | - |
| Mean EQ-5D-5 L VAS/100 | 75 (15.5) | - | - |
| EQ-5D-5 L Index (SD) | 0.74 (0.099) | - | - |
| Mean number of treatment visits (range) | 8 (7–8) | - | - |
kPa, kilopascals; NRS, Numerical Rating Scale for pain; NDI, Neck Disability Index; EQ-5D-5 L, Euroquol; VAS, Visual Analogue Scale; †, (unpaired) t test; ‡, Fisher’s exact test.
Figure 4Baseline IV-RoM in patients and controls.
Hypomobile levels identified by palpation (C2-C5) and confirmed by measurement (n = 87)*
| C2-3 | 14 | 6 | 43 | 0.00 | 0.500 |
| C3-4 | 7 | 2 | 29 | 0.06 (−0.064-0.193) | 0.163 |
| C4-5 | 7 | 6 | 86 | 0.04 (−0.160-0.248) | 0.336 |
| Pooled | 28 | 14 | 50 | 0.06 (−0.032-0.158) | 0.096 |
*Number of hypomobile levels identified on palpation and confirmed by measurement as movement of <5 degrees in flexion or extension at the identified or adjacent level.
Correlations between change scores and levels that increased range above MDC in flexion or extension
| NRS/10 | 5 (1.5) | 2 (1.6) | p < 0.0001 | 52% | 0.02 (−0.350- 0.383) | 0.92 |
| (40.6-63.4) | ||||||
| NDI/50 | 13 (6.7) | 6 (4.9) | p < 0.0001 | 48% | 0.12 (−0.260- 0.464) | 0.54 |
| (36.2- 59.8) | ||||||
| EQ-5D VAS/100 | 75 (15.5) | 84 (14.9) | p = 0.001 | 6% | −0.12 (−0.465- 0.259) | 0.54 |
| (−10.0- 22.0) | ||||||
| EQ-5D Index | 0.74 (0.10) | 0.82 (0.11) | p < 0.0001 | 9% | −0.19 (−0.518- 0.192) | 0.33 |
| (4.4- 13.6) | ||||||
| PGIC/-10 to +10 | - | - | - | 87% improved** | −0.05 (−0.407- 0.325) | 0.81 |
Wilcoxon signed rank test; ‡, Spearman’s rank correlation coefficient.
*Increased IV-RoM = number of inter-vertebral levels increased in range above MDC **At least 30% improvement.
Figure 5Manipulations received by levels that increased in range. Scatterplot showing the number of manipulations received against the number of intervertebral levels that increased their range above MDC. * = Spearman rank correlation.